English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Current pharmacogenetic developments in oral anticoagulation therapy: The influence of variant VKORC1 and CYP2C9 alleles

Oldenburg, J., Bevans, C. G., Fregin, A., Geisen, C., Müller-Reible, C., & Watzka, M. (2007). Current pharmacogenetic developments in oral anticoagulation therapy: The influence of variant VKORC1 and CYP2C9 alleles. Thrombosis and Haemostasis, 98(3), 570-578.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Oldenburg, Johannes, Author
Bevans, Carville G.1, Author           
Fregin, Andreas, Author
Geisen, Christof, Author
Müller-Reible, Clemens, Author
Watzka, Matthias, Author
Affiliations:
1Department of Structural Biology, Max Planck Institute of Biophysics, Max Planck Society, ou_2068291              

Content

show
hide
Free keywords: VKORC1, CYP2C9, acenocoumarol, phenprocoumon, warfarin, genotype
 Abstract: -

Details

show
hide
Language(s): eng - English
 Dates: 2007
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: eDoc: 321439
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Thrombosis and Haemostasis
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 98 (3) Sequence Number: - Start / End Page: 570 - 578 Identifier: -